Grove Bank & Trust lowered its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 66.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 819 shares of the semiconductor company’s stock after selling 1,616 shares during the quarter. Grove Bank & Trust’s holdings in Synopsys were worth $385,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC increased its stake in Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC boosted its position in shares of Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after purchasing an additional 79 shares in the last quarter. NewEdge Advisors LLC grew its stake in shares of Synopsys by 15.1% in the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock valued at $1,291,000 after buying an additional 395 shares during the period. TD Waterhouse Canada Inc. increased its position in Synopsys by 14.7% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 876 shares of the semiconductor company’s stock valued at $457,000 after buying an additional 112 shares in the last quarter. Finally, Mufg Securities Americas Inc. increased its position in Synopsys by 25.3% in the 2nd quarter. Mufg Securities Americas Inc. now owns 3,427 shares of the semiconductor company’s stock valued at $1,757,000 after buying an additional 691 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $420.32 on Monday. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The stock has a market cap of $80.52 billion, a PE ratio of 65.27, a price-to-earnings-growth ratio of 3.42 and a beta of 1.15. The stock’s fifty day simple moving average is $453.33 and its two-hundred day simple moving average is $456.54. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.
Analysts Set New Price Targets
SNPS has been the topic of several recent research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. JPMorgan Chase & Co. upped their target price on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Morgan Stanley reissued an “equal weight” rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Finally, The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the company a “buy” rating in a research note on Wednesday, February 25th. Eight investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $531.00.
Check Out Our Latest Analysis on Synopsys
Insider Buying and Selling
In other Synopsys news, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.56% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
